RT Journal Article
SR Electronic
T1 Association between <em>CCR5</em>-Δ32 homozygosity and mortality in 37,650 participants from three U.S.-based cohorts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19006619
DO 10.1101/19006619
A1 Jiang, Xia
A1 Huang, Hongyan
A1 Grodstein, Francine
A1 Kraft, Peter
YR 2019
UL http://medrxiv.org/content/early/2019/10/03/19006619.abstract
AB An analysis of 409,693 UK Biobank participants recently published in Nature Medicine identified a relative 21% increase in all-cause mortality among participants who were homozygous for the Δ32 deletion in the C-C motif chemokine receptor 5 gene (CCR5).1 This is a timely and potentially cautionary result in light of He Jiankui’s controversial germline editing of CCR5 to induce mutations that putatively mimic the effects of Δ32, which is known to reduce the risk of HIV infection. To provide additional evidence on the association between the Δ32 deletion and mortality and assess its generalizability, we present results from three large-scale population-based US cohorts: the Nurses’ Health Study (NHS),2 the NHSII and the Health Professional Follow-Up Study (HPFS).3Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by U.S. National Institutes of Health Grants U01 CA186107, R01 CA49449, U01 CA176726, R01 CA67262, and U01 CA167552. Dr. Jiang is supported by the International Postdoc Grant from the Swedish Research CouncilAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData are available upon request, see: https://www.nurseshealthstudy.org/researchers and https://sites.sph.harvard.edu/hpfs/for-collaborators/.